97 related articles for article (PubMed ID: 8062928)
1. Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation.
Gabel B; Yao Z; McLeod RS; Young SG; Koschinsky ML
FEBS Lett; 1994 Aug; 350(1):77-81. PubMed ID: 8062928
[TBL] [Abstract][Full Text] [Related]
2. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
[TBL] [Abstract][Full Text] [Related]
3. Sequences within the amino terminus of ApoB100 mediate its noncovalent association with apo(a).
Gabel BR; McLeod RS; Yao Z; Koschinsky ML
Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1738-44. PubMed ID: 9812912
[TBL] [Abstract][Full Text] [Related]
4. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
5. Mutation of lysine residues in apolipoprotein B-100 causes defective lipoprotein[a] formation.
Liu CY; Broadhurst R; Marcovina SM; McCormick SP
J Lipid Res; 2004 Jan; 45(1):63-70. PubMed ID: 13130121
[TBL] [Abstract][Full Text] [Related]
6. Identification of a critical lysine residue in apolipoprotein B-100 that mediates noncovalent interaction with apolipoprotein(a).
Becker L; McLeod RS; Marcovina SM; Yao Z; Koschinsky ML
J Biol Chem; 2001 Sep; 276(39):36155-62. PubMed ID: 11473115
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the mechanism of lipoprotein(a) assembly.
Koschinsky ML; Marcovina SM; May LF; Gabel BR
Clin Genet; 1997 Nov; 52(5):338-46. PubMed ID: 9520124
[TBL] [Abstract][Full Text] [Related]
8. The apolipoprotein B3304-3317 peptide as an inhibitor of the lipoprotein (a):apolipoprotein B-containing lipoprotein interaction.
Trieu VN; Olsson U; McConathy WJ
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):17-22. PubMed ID: 7717972
[TBL] [Abstract][Full Text] [Related]
9. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein (a) in vivo.
Callow MJ; Rubin EM
J Biol Chem; 1995 Oct; 270(41):23914-7. PubMed ID: 7592581
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a).
Cheesman EJ; Sharp RJ; Zlot CH; Liu CY; Taylor S; Marcovina SM; Young SG; McCormick SP
J Biol Chem; 2000 Sep; 275(36):28195-200. PubMed ID: 10837476
[TBL] [Abstract][Full Text] [Related]
11. Expression of apolipoprotein(a) kringle IV type 9 in Escherichia coli: demonstration of a specific interaction between kringle IV type 9 and apolipoproteinB-100.
Rahman M; Jia Z; Gabel BR; Marcovina SM; Koschinsky ML
Protein Eng; 1998 Dec; 11(12):1249-56. PubMed ID: 9930675
[TBL] [Abstract][Full Text] [Related]
12. Bacterial expression and characterization of human recombinant apolipoprotein(a) kringle IV type 9.
Chung FZ; Wu LH; Lee HT; Mueller WT; Spahr MA; Eaton SR; Tian Y; Settimi PD; Oxender DL; Ramharack R
Protein Expr Purif; 1998 Jul; 13(2):222-8. PubMed ID: 9675066
[TBL] [Abstract][Full Text] [Related]
13. Carboxyl-terminal truncation impairs lipid recruitment by apolipoprotein B100 but does not affect secretion of the truncated apolipoprotein B-containing lipoproteins.
McLeod RS; Zhao Y; Selby SL; Westerlund J; Yao Z
J Biol Chem; 1994 Jan; 269(4):2852-62. PubMed ID: 8300620
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation.
Gabel BR; May LF; Marcovina SM; Koschinsky ML
Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1559-67. PubMed ID: 8977462
[TBL] [Abstract][Full Text] [Related]
15. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein.
McCormick SP; Linton MF; Hobbs HH; Taylor S; Curtiss LK; Young SG
J Biol Chem; 1994 Sep; 269(39):24284-9. PubMed ID: 7929084
[TBL] [Abstract][Full Text] [Related]
16. Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion.
Youssef A; Clark JR; Marcovina SM; Boffa MB; Koschinsky ML
Arterioscler Thromb Vasc Biol; 2022 Mar; 42(3):289-304. PubMed ID: 35045727
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of the contribution of weak lysine-binding sites present within apolipoprotein(a) kringle IV types 6-8 to lipoprotein(a) assembly.
Becker L; Cook PM; Wright TG; Koschinsky ML
J Biol Chem; 2004 Jan; 279(4):2679-88. PubMed ID: 14581473
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice expressing human ApoB95 and ApoB97. Evidence that sequences within the carboxyl-terminal portion of human apoB100 are important for the assembly of lipoprotein.
McCormick SP; Ng JK; Cham CM; Taylor S; Marcovina SM; Segrest JP; Hammer RE; Young SG
J Biol Chem; 1997 Sep; 272(38):23616-22. PubMed ID: 9295301
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of apolipoprotein B secretion by taurocholate is controlled by the N-terminal end of the protein in rat hepatoma McArdle-RH7777 cells.
Elzinga BM; Baller JF; Mensenkamp AR; Yao Z; Agellon LB; Kuipers F; Verkade HJ
Biochim Biophys Acta; 2003 Dec; 1635(2-3):93-103. PubMed ID: 14729072
[TBL] [Abstract][Full Text] [Related]
20. The binding of animal low-density lipoproteins to human apolipoprotein(a).
Trieu VN; McConathy WJ
Biochem J; 1995 Aug; 309 ( Pt 3)(Pt 3):899-904. PubMed ID: 7639708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]